StockNews.com assumed coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a research report released on Wednesday morning. The brokerage issued a sell rating on the basic materials company’s stock.
Arcadia Biosciences Trading Up 1.5 %
Shares of RKDA opened at $6.18 on Wednesday. The stock has a market cap of $8.44 million, a PE ratio of -1.44 and a beta of 1.19. Arcadia Biosciences has a 1 year low of $1.85 and a 1 year high of $10.31. The stock has a 50 day simple moving average of $4.30 and a 200-day simple moving average of $3.39.
Arcadia Biosciences Company Profile
Recommended Stories
- Five stocks we like better than Arcadia Biosciences
- How to Find Undervalued Stocks
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- Profitably Trade Stocks at 52-Week Highs
- 2 Drone Stocks Surging from Increased Media Attention
- What Do S&P 500 Stocks Tell Investors About the Market?
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.